title: Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group.
authors.forename: P
authors.initials: P
authors.lastname: Sedlácek
authors.forename: J
authors.initials: J
authors.lastname: Trka
authors.forename: J
authors.initials: J
authors.lastname: Zuna
authors.forename: O
authors.initials: O
authors.lastname: Hrusák
authors.forename: L
authors.initials: L
authors.lastname: Honzátková-Krsková
authors.forename: J
authors.initials: J
authors.lastname: Stary
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D050676:Core Binding Factor Alpha 2 Subunit; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology / Q000628:therapy; D018183:Transplantation Chimera; D014184:Transplantation, Homologous; D000097764:ETS Translocation Variant 6 Protein
chemical_list: D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; C102421:TEL-AML1 fusion protein; D000097764:ETS Translocation Variant 6 Protein